20 hours ago
1
Jacob Wackerhausen/iStock via Getty Images
- BioNTech SE (NASDAQ:BNTX) shares rose ~8% in premarket trading on Friday after the company and partner Duality Biologics reported positive Phase 3 trial results for their breast cancer treatment.
- The drug, tested in China, showed it was more effective than an existing
English (US) ·